(Insert Table 3 here)

Second-round survey

Most of the statements (92.0%) reached consensus in this round. Similar to the first-round survey results, the statements’ agreement scores were high particularly on statements related to community surveillance and home visits for women with HDP (mean agreement scores: 98.0%). Five statements did not reach consensus in this round and the statements were re-tested in the third-round survey (Please refer to Table 2 and the supplementary table).
Seven participants also revised their responses to statements in the first-round survey and increased the agreement scores to above 70.0% for three statements: ‘systemic lupus erythematosus as a risks factor for preeclampsia ’ (72.9%), ‘serum creatinine as a baseline examination for women with preeclampsia risk factors ’ (70.8%) and ‘low dose aspirin prescription by GPs ’ (70.8%).
Some participants in the free-text questions in this round raised further opinions regarding authority of HDP in primary care, such as suggesting different management of mild and severe preeclampsia based on their usual practice and a need for a government policy to facilitate the pathways’ implementation in practice (Table 3). Again, a participant also wrote another limitation in practice, i.e that only certain medicine available in primary care.